Clinical Trial Update: Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update analyzing adherence in subjects treated with Differin Gel 0.1% for moderate to severe acne vulgaris; results completed and posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Differin Gel 0.1% (adapalene 0.1%)

Snippet

Sponsor: Wake Forest University | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2017-03-30